Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics.
about
Metabolomic profiling of hormone-dependent cancers: a bird's eye viewMRS-based Metabolomics in Cancer Research.Performance Evaluation and Online Realization of Data-driven Normalization Methods Used in LC/MS based Untargeted Metabolomics Analysis.Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft modelsSerum Metabolomic Profiles for Breast Cancer Diagnosis, Grading and Staging by Gas Chromatography-Mass Spectrometry.Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples.Breast Tissue Metabolism by Magnetic Resonance Spectroscopy.In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsyPrognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.Early detection of recurrent breast cancer using metabolite profiling.Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry.MetaboID: a graphical user interface package for assignment of 1H NMR spectra of bodyfluids and tissues.HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors.ADEMA: an algorithm to determine expected metabolite level alterations using mutual information.Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgeryApplication of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate modelMetabolic characterization of triple negative breast cancer.The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancerMetabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRIThe Role of High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy for Predicting the Invasive Component in Patients with Ductal Carcinoma In Situ Diagnosed on Preoperative BiopsyMetabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery.Impact of Freezing Delay Time on Tissue Samples for Metabolomic Studies.Metabolic profiling: are we en route to better diagnostic tests for cancer?Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer.Biomarker Discovery and Translation in Metabolomics.The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.Metabolic clusters of breast cancer in relation to gene- and protein expression subtypesGenome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse.Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypesInterplay of choline metabolites and genes in patient-derived breast cancer xenografts.Triple-negative breast cancer: present challenges and new perspectives.Metabolomics in the fields of oncology: a review of recent research.Application of chemometric techniques in search of clinically applicable biomarkers of disease.Ratio analysis nuclear magnetic resonance spectroscopy for selective metabolite identification in complex samples.Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion.Tissue-Based Metabolomics to Analyze the Breast Cancer Metabolome.Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts.Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer.Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion.
P2860
Q28084834-EB2910C0-7969-4030-8A13-EFC616EABBF5Q30842175-7502C3EB-D0B6-4F1C-8616-A81BBFDBC7CAQ31148475-AC76D1C5-D1C1-4ACE-96F4-C161C93F7F43Q33660965-DC92A7D3-7E4A-4D8E-938C-C1E8FA0CF3E0Q33687106-740F3D78-3645-4E33-BEED-0FBBF1BFA372Q33844930-F66B7601-0236-4465-899A-EB4F2B922EEFQ33844954-AC26BAD4-AF03-4CB9-98BE-9322D7C0DFE5Q34016780-8E845DA6-410F-495F-9D33-E4F76C3CDB61Q34058288-AF008418-4869-4BC2-88C4-6334A21CC288Q34140986-055DE39F-E1EA-47BE-9C71-5316800E196DQ34369288-41FFB9F5-BE91-4C76-8AB4-8B4E1FB04AA1Q34406520-4276596D-E295-4E88-9FCC-C6A30C964375Q34509054-3B3BEAD6-5E82-4E34-BBAF-267766F048D4Q34525558-F805DA5D-75A3-4922-8BE4-2A5398C99BADQ34557978-61BB6EFA-5AE7-4CE2-8E77-459772EF1240Q34684585-D7DD8A7F-7E97-427A-A094-94E49E6E68FBQ34724200-F31AA329-5EC6-4AB3-9D8A-BE4A71C679F3Q34967995-E63566E9-6AB3-4069-B92C-427E55D777A1Q35686588-3BF43FCB-B5A7-4AF5-A3A8-F68488937B70Q36086056-77828847-09A3-487C-883B-BF80EB3D46D7Q36113082-3D890CDA-4BBC-417F-982A-2F8A6EEAAE07Q36245156-0CA3FCD9-D628-4530-8103-3283E5C8100CQ36514020-9B4D6508-0E6F-4670-8A98-85F87822985EQ36519905-CE6D8771-F10D-4EC1-AD49-BAED70456C35Q36822535-25A684D4-96B5-4924-9455-21EBE58D3E67Q36845593-89F17DB5-FCA2-4928-A930-1EE3B885A40AQ36867985-96249C05-D41B-4762-84AA-01CFE855FE78Q37040438-0D0B1458-B50B-4EF6-981D-68566EAD4303Q37326689-15312AF5-0949-4126-BFCD-C137D8D6A4EDQ37474410-C7482E84-8235-4E16-9A04-3C6E4A79F30CQ37689772-79EFDD31-41B0-473C-955B-563DF2647FA9Q37764168-74B66E2B-F8A6-4BCA-999B-C57B7714510DQ37986476-EF5C0C33-7AB6-4FC0-A909-7D2045732FEFQ38243626-43DC06B5-4C21-457B-91D3-7F06EA2749C8Q38708752-135052AD-D194-481B-B214-87C5E51D8CB8Q38760909-E267D76F-E8B9-43D4-8D43-810D9019D985Q38936269-9864B361-38EF-46EC-BFB2-D4E70D25E699Q39521987-F43FD3E7-9369-43E3-8804-CE0E8003D3AFQ41134662-D12EBB63-8CB1-4E5B-B356-9F93B6A4C580Q41981553-41E62942-B7DC-4135-AE8A-CB04E5A0ABCD
P2860
Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Multivariate modeling and pred ...... factors using MR metabolomics.
@en
Multivariate modeling and pred ...... factors using MR metabolomics.
@nl
type
label
Multivariate modeling and pred ...... factors using MR metabolomics.
@en
Multivariate modeling and pred ...... factors using MR metabolomics.
@nl
prefLabel
Multivariate modeling and pred ...... factors using MR metabolomics.
@en
Multivariate modeling and pred ...... factors using MR metabolomics.
@nl
P2093
P50
P356
P1476
Multivariate modeling and pred ...... factors using MR metabolomics.
@en
P2093
David E Axelson
Guro F Giskeødegård
Hans E Fjøsne
Maria T Grinde
Steinar Dahl
P304
P356
10.1021/PR9008783
P577
2010-02-01T00:00:00Z